To the best of our knowledge, this is the first study identifying amino-acid metabolic gene PSPH associated with a worse prognosis in neuroblastoma, possibly along with infiltration levels of certain immune cells in the TME. The gene discussed is PSPH; the disease is neuroblastoma.